Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 Sep 7;8:100159. doi: 10.1016/j.hazadv.2022.100159

Relationship between SARS-CoV-2 in wastewater and clinical data from five wastewater sheds

Brian A Wartell a,b, Sudheer Ballare a,b, Shahrzad Saffari Ghandehari a,b, Patricia Dotingco Arcellana a,b, Camila Proano a,b, Devrim Kaya a,c, Debra Niemeier a,b, Birthe V Kjellerup a,b,
PMCID: PMC9448702  PMID: 36619827

Abstract

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has resulted in a global pandemic starting in 2019 with nearly 500 million confirmed cases as of April 2022. Infection with SARS-CoV-2 is accompanied by shedding of virus in stool, and its presence in wastewater samples has been documented globally. Therefore, monitoring of SARS-CoV-2 in wastewater offers a promising approach to assess the pandemic situation covering pre-symptomatic and asymptomatic cases in areas with limited clinical testing. In this study, the presence of SARS-CoV-2 RNA in wastewater from five wastewater resource recovery facilities (WRRFs), located in two adjacent counties, was investigated and compared with the number of clinical COVID-19 cases during a 2020-2021 outbreak in United States. Statistical correlation analyses of SARS-CoV-2 viral abundance in wastewater and COVID-19 daily vs weekly clinical cases was performed. While a weak correlation on a daily basis was observed, this correlation improved when weekly clinical case data were applied. The viral fecal indicator Pepper Mild Mottle Virus (PMMoV) was furthermore used to assess the effects of normalization and the impact of dilution due to infiltration in the wastewater sheds. Normalization did not improve the correlations with clinical data. However, PMMoV provided important information about infiltration and presence of industrial wastewater discharge in the wastewater sheds. This study showed the utility of WBE to assist in public health responses to COVID-19, emphasizing that routine monitoring of large WRRFs could provide sufficient information for large-scale dynamics.

Keywords: SARS-CoV-2, COVID-19, Wastewater sheds, Correlation, Pepper Mild Mottle Virus (PMMoV), Wastewater-based epidemiology (WBE)

Graphical abstract

Image, graphical abstract

1. Introduction

The novel coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome-Corona Virus-2) has led to the spread of the COVID-19 worldwide with nearly 500 million confirmed cases and over 6 million deaths, as of the beginning of April 2022 (World Health Organization, 2022). The main reasons for the wide spread of the initial outbreak (Alpha strain) are the long incubation period (up to 14 days; median: 4-5 days) and simultaneous viral shedding and transmission by asymptomatic infected individuals precluded from clinical testing data (Chen et al., 2020; Xu et al., 2020). Wastewater-based epidemiology (WBE) has pre-COVID-19 been utilized as a successful surveilling and early warning tool to monitor poliovirus and SARS-CoV-1 (Jafferali et al., 2020; Michael-Kordatou et al., 2020) in the wastewater shed (catchment area population of wastewater resource recovery facilities, WRRFs) (Xagoraraki and O'Brien, 2020). Studies over the last decades have shown that sewage monitoring of pathogens can be effectively used to determine the presence and relative abundance of the pathogen within a community (Larsen and Wigginton, 2020; Peccia et al., 2020) thus informing public health interventions (Asghar et al., 2014). In addition, sewage, or wastewater monitoring can help ascertain whether the transmission of a pathogen (e.g., a virus) is declining or increasing (Larsen and Wigginton, 2020). Specifically, wastewater surveillance has been used to monitor both the prevalence and severity of outbreaks by analyzing viral RNA in wastewater systems throughout a variety of community types (D'Aoust et al., 2020; Jafferali et al., 2020).

Wastewater surveillance of viral RNA and the trends, also known as wastewater-based epidemiology (WBE), provides unique insights not afforded by clinical testing alone. Due to a combination of limited equipment or capabilities in addition to a high level of an infected population being asymptomatic (Gandhi et al., 2020), reported numbers of infected individuals may be below the true infected count (Lu et al., 2020b). WBE can therefore provide complementary information as it is not procedure-intensive and also can detect RNA from asymptomatic individuals (Michael-Kordatou et al., 2020; Wu et al., 2020b). An additional benefit is that WBE is unbiased as it is centered around a community or select population, rather than particular individuals, and there is no discrepancy for those with underlying or pre-existing conditions and includes also those individuals not reporting their symptoms or seeking healthcare (Wu et al., 2020b). WBE can detect low viral concentrations in large wastewater volumes, although this can depend on environmental conditions, and sensitivity of the analytical procedures (Lu et al., 2020a; Wu et al., 2020a).

As domestic wastewater is prone to the impact of dilution (e.g., via rainfall, snow melt, stormwater, industrial wastewater), fecal indicator viruses such as the Pepper Mild Mottle Virus (PMMoV) are used to normalize analytical results from wastewater samples (Medema et al., 2020). Currently, the U.S. Centers for Disease Control and Prevention (CDC) utilizes PMMoV as one of its two primary fecal indicators, specifically for the normalization of SARS-CoV-2 levels in wastewater (Centers for Disease Control and Prevention (CDC), 2022). PMMoV is one of the most abundant viruses in the human gut (Kitajima et al., 2018; Rosario et al., 2009). Therefore, it has often been used by researchers to determine the amount of fecal solids in a sample (D'Aoust et al., 2020) and can be quantified and used to adjust reported SARS-CoV-2 values to account for the relative extent at which the sample has been diluted (Ahmed et al., 2021; Medema et al., 2020). Additionally, PMMoV is found to be stable in wastewater and shows low seasonal variations (Kitajima et al., 2018) Another benefit is that PMMoV, despite possessing slight diet-based variability, is present in the vast majority of human fecal samples (Hsu et al., 2022; Kitajima et al., 2018).

The first objective of this study was to evaluate the feasibility of selected methodologies for wastewater data analysis and to enhance analytical laboratory procedures for wastewater analysis of viral RNA. The second objective was to evaluate trends of SARS-CoV-2 abundance compared to observed clinical surveillance data for five differently-sized wastewater sheds serving the five WRRFs. Previous studies have indicated that correlations are often observed as trends, being compared on a weekly basis (Stadler et al., 2020; Weidhaas et al., 2021). However, some studies have had success in generating correlations utilizing daily clinical cases with frequent wastewater testing, albeit often with a slight time lag (Feng et al., 2021; Karthikeyan et al., 2021b). Therefore, this study investigates whether there is an improvement in correlation when shifting from a data-point based comparison to a weekly analysis. The third objective of this study was to investigate the benefit of data normalization with PMMoV in obtaining improved correlations between wastewater data and clinical viral cases of SARS-CoV-2.

2. Materials and Methods

Wastewater samples were collected and analyzed from five WRRFs, located in two adjacent counties in the same geographical region of an urban nature. Samples were collected during the period of October 15, 2020 to April 15, 2021 by operators at the WRRFs (Table 1 ).

Table 1.

Information about the wastewater sheds and the service areas.

WRRF Estimated 2020 Population Service area (square miles) Flow (L/day)
WRRF1 ∼5,300 4.9 0.33·107
WRRF2 ∼202,000 46.9 6.1·107
WRRF3 ∼56,000 13.9 2.5·107
WRRF4 ∼175,000 102.4 9.5·107
WRRF5 ∼241,000 126.7 8.4·107

Samples were collected primarily as flow-dependent composite samples (24-hr) collected in volumes of either 400-500 mL or 900-1000 mL. All samples were stored at 4°C during and post-sampling and transported to the UMD laboratory on ice for processing. and often processed immediately. Portions of the samples were transferred to two 50 mL Falcon conical centrifuge tubes (Corning, Corning, NY, USA) at a fill volume of 45 mL per tube after shaking. In the event that samples could not be processed immediately, samples were stored at 4°C for up to an additional 48 hours.

2.1. Sample concentration and quantification

All samples were concentrated from 90 mL (as two 45 mL aliquots) to approximately 1 mL using the following method, as initially determined by Kaya et al. (2022) as the preferred procedure.

2.1.1. Centrifugation

The 50 mL Falcon conical tubes were centrifuged in a benchtop centrifuge (Allegra X-22, Beckman-Coulter, Brea, CA, USA) with a swinging-bucket rotor, at 3,400 G for 20 min to remove the solid fraction and large particles. The supernatant was transferred to new 50 mL Falcon centrifuge tubes and apportioned over three centrifugal cycles into 15 mL Amicon Ultra-15 Centrifugal Filter Devices with a cut-off of 100 kDa (Millipore, Amsterdam, the Netherlands) for 15 min at 3,400 G. If the liquid did not pass through the device during the allotted runtime, additional centrifugation time was provided. Additionally, if a sample would have a higher solids content (a rare occurrence), the sample would have to undergo further centrifugation as to avoid noted inhibition of the RT-PCR signal.

2.1.2. Concentration

Once centrifugation yielded a total residual liquid (two 45 mL aliquots combined) of less than 1.5 mL, the duplicate samples were combined, and the concentrated sample was adjusted to 1 mL with RNase-free water. After rinsing and agitation, the sample was transferred to sterile 1.5 mL RNase-free Microfuge tubes (Invitrogen, Carlsbad, CA, USA) for subsequent RNA extraction.

2.1.3. RNA extraction

Quick-RNATM Miniprep kits (Zymo Research, Irvine, CA, USA) were used to extract RNA. Specific modification included utilizing 0.3 mL of each sample and 0.6 mL of Lysis buffer. As per the protocol, final RNA volume for each sample was 0.1 mL. Reverse transcription was performed as outlined in the publication by Kaya et al. (2022), section 2.8. A noted exception was the use of a smaller volume of reverse transcriptase (1 µL rather than 1.25 µL), in order to preserve stock (see Table 2 for full details). This modification was made for most samples and no discrepancies were observed by this reduction.

Table 2.

Modified Standard Protocol for cDNA Synthesis

Reaction mix 1: vol. /25 µL, µL vol. /50 µL, µL
Random Hexamer (primer mix) (60 µM) 1.5 3
dNTP mix (10mM) 1.25 2.5
H2O (RNase-free), µL 3.25 6.5
Sample RNA 6 12
Total vol 12 24
Reaction mix 1 denatured for 5 minutes at 70°C. Spun/centrifuged briefly and put on ice for 2 min.
Reaction mix 2: vol. /25 µL, µL vol. /50 µL, µL
5X ProtoScript II Buffer 5.25* 10
RNase Inhibitor (40 U/µl) 0.5 1
0.1M DTT 2.5 5
Protoscript II RT (200U/µl) 1* 2.5
H2O (RNase-free) 3.75 7.5
Total vol 13 26
Reaction mix 2 added and samples incubated at 42°C for 1hr. Enzyme inactivated at 70°C for 20 min and kept at 4°C until tubes removed from machine.

Some October and early November samples used 5 µL of buffer and 1.25 µL of transcriptase.

2.1.4. RT-qPCR

Protocols were predicated upon CDC recommendations (Corman et al., 2020; Lu et al., 2020c). SARS-CoV-2 gene (N) plasmids (2019-nCoV RUO Kit - Cat. No:10006625, IDT) were linearized via manufacturer's protocol prior to use as an RT-PCR standard. Standard curves for assays were prepared by performing serial dilutions (10-fold) in order to verify quantitative results. Additional specifications used are outlined in Kaya, et al. (2022).

RT-PCR was conducted using a CFX Connect Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA), using standard and calibration curves to determine the viral concentration. TaqMan® (Promega, Madison, WI, USA) Master primer mix was used along with specific primers and probes (Table 3 ). Positive control was established via standard curves run on each plate, when performing RT-PCR. Specifically, linearized standards of the relevant plasmid (e.g., N or PMMoV) were added in triplicate to each well plate. N-plasmids, used for N1 and N2 analysis, ranged from 101-105 gc/L in concentration. De-ionized water was used as a method/extraction blank and RNAse-free water was used as negative controls in each PCR well. These were done either in duplicate or triplicate. Both the N1 and N2 primer mixes were diluted to preserve stock, and it was confirmed that there was no loss, nor any significant change compared to undiluted stock. The initial viral load (RNA) in the original wastewater sample was calculated. Data was measured via RT-PCR utilizing either the N1 or N2 gene, with both genes being analyzed for comparison.

Table 3.

Primers and probes used in this study.

Description Oligonucleotide Sequence (5’>3’) product length, bp Final Conc., nM Ref.
N1 FWD GAC CCC AAA ATC AGC GAA AT 72 67 (Lu et al., 2020c)
REV TCT GGT TAC TGC CAG TTG AAT CTG 67
Probe [FAM]-ACC CCG CAT TAC GTT TGG TGG ACC-[BHQ1] 17
N2 FWD TTA CAA ACA TTG GCC GCA AA 67 67 (Lu et al., 2020c)
REV GCG CGA CAT TCC GAA GAA 67
Probe [FAM]-ACA ATT TGC CCC CAG CGC TTC AG-[BHQ1] 17
BRSV FWD GCAATGCTGCAGGACTAGGTATAAT 124 500 (Boxus et al., 2005)
REV ACACTGTAATTGATGACCCCATTCT 500
Probe [HEX]-ACCAAGACT-[ZEN]-TGTATGATGCTGCCAAAGCA-[3IABkFQ] 250
PMMoV FWD GAG TGG TTT GAC CTT AAC GTT TGA 500 (Lee et al., 2018)
REV TTG TCG GTT GCA ATG CAA GT ∼1900 500
Probe 6-FAM-CCT ACC GAA GCA AATG-MGB 250

2.2. Process control - Bovine respiratory syncytial virus (BRSV)

Bovine Respiratory Syncytial Virus (BRSV) (Inforce 3 Cattle VaccineTM, Zoetis, Parsippany, NJ, USA) was used as a surrogate (process control), as it was used to determine the level of recovery. BRSV was chosen due to its inherent stability (Bivins et al., 2021b) and availability. Additionally, BRSV was found to functional well as a surrogate due to its morphological similarities to the SARS-CoV-2 virus and its documented use as an extraction control for drinking and wastewater samples (Bivins et al., 2021a; Bivins et al., 2021b; Valarcher and Taylor, 2007)

For each 45 mL aliquot of sample, a 1:1000 ratio (45 µL:45 mL) of BRSV stock concentration (median concentration of 1011 ± 101 gc/L) was added prior to all sample processing, including centrifugation. The reported recovery determined via BRSV analysis was approximately 8.5% and most values ranged between 0.5-20% consistent with findings in similar studies (Alygizakis et al., 2020; Bivins et al., 2021b; Prado et al., 2021), Several studies (Li et al., 2021; Maestre et al., 2021) reported difficulty in utilizing BRSV as a normalization approach and obtaining high recoveries. However, in this study it was a beneficial surrogate to determine if a WRRF sample was negative (i.e., below the threshold), that it was not due to a procedural error, but rather either that it was a true value or that the low value was due to an error with the N-gene primer mix or standards.

2.3. Normalization - Pepper Mild Mottle Virus (PMMoV)

PMMoV RNA was quantified via RT-PCR in an identical manner to SARS-CoV-2 and BRSV primers. The specific primers used to detect the Pepper Mild Mottle Virus (PMMoV) can be seen in Table 3. A series of 10-fold dilutions were used to establish a proper calibration curve (5-point) and all samples were analyzed at least in duplicate, utilizing at least one negative and positive control. PMMoV values ranged from 2 × 104 gc/mL to 4 × 107 gc/mL but typically were in the 105-106 gc/mL range. The average Ct value was 27.54 ± 2.01 min.

3. Results and discussion

3.1. Non-adjusted data and trends

Monitoring of SARS-CoV-2 RNA from the five different sized WRRFs in the Mid-Atlantic region, USA was performed during the period of Oct.15, 2020 – Apr. 15, 2021 (Fig. 1 ). The results showed presence of SARS-CoV-2 in most samples with a presence of approximately 0.5-1.5 × 105 gene copies per liter, which is consistent with the literature. Ct cycle values of the N1 plasmid ranged between 31.3 – 40.3 min, with an average value of 36.09 ± 1.56 min. Less than 3% of values had a Ct ≥ 39.0 min. Ct cycle values of the N2 plasmid processed with a delay and therefore ranged between 35.6 – 45.1 min, with an average value of 40.21 ± 1.83 min. Only 2% of values had a Ct ≥ 44.0 min. The threshold of output values, when converted for starting concentration, was approximately 1 × 104 gene copies per liter (gc/L).

Fig. 1.

Fig. 1

Calculated values for SARS-CoV-2 genes N1 (top) and N2 (bottom) for all WRRFs over the studied duration with an approximate trend illustrated (shown as solid green).

Converted values, calculated to determine initial starting SARS-CoV-2 viral concentration were obtained via Eq. 1 and ranged from 1.9 × 104 – 3.8 × 107 gc/L for N1 and 1.0 × 104 – 8.7 × 106 gc/L for N2, with average values of 3.1 × 106 and 8.5 × 105 gc/L, respectively. As noted in the literature (Pérez-Cataluña et al., 2021; Saththasivam et al., 2021; Sherchan et al., 2020) and conferring with other studies, N2 values can have higher Ct values, leading to lower concentrations (gc/L) than for N1.

Startingqty.determinedbyPCR(gc/μl)*Vol.ofcDNAusedforPCRrxn(uL)TotalPCRvol.inwell*totalcDNAvol.(mL)vol.ofRNAused(mL)*finalvol.ofallRNAextractedvol.ofconcentrateusedinRNAextraction*totalvol.ofconcentratetotalinitialsamplevol.*1000uLmL1000mLL=gc/L (1)

The results indicated that the presence of SARS-CoV-2 varied between wastewater sheds but the variation was not statistically significant with standard deviations ranging from 2.2 - 7.2 × 106 gc/L for N1 values and from 0.38 - 1.5 × 106 gc/L for N2 values. WRRF3 had the highest average value over the six-month monitoring period (4.4-5.2 × 106 gc/L and 8.8-9.9 × 105 gc/L for N1 and N2 values, respectively), as well as the greatest standard deviation, but fell within the margin of error. WRRF5 had the lowest average values (1.4-2.3 × 106 gc/L and 3.2-4.5 × 105 gc/L for N1 and N2 values, respectively), and also the lowest maximum values and standard deviations for both N1 and N2. This was in addition to WRRF5 having the greatest incidence of values falling below the threshold. These lower values of WRRF5 may be due to flow-related dilution rather than demographic or clinical reasons. Overall, there was a strong correlation between the reported N1 and N2 values (see SI for full comparison), and the average values over time for N1 values with and without normalization (Fig. 2 ).

Fig. 2.

Fig. 2

The average SARS-CoV-2 values from the five WRRFs per sampling date with and without PMMoV normalization for the N1 gene.

3.2. Correlations between WRRF data and Covid-19 cases

The results obtained from each WRRF were compared with the reported Covid-19 cases for all zip codes contained within the service area of the individual wastewater sheds. Correlations were observed both visually (graph-based overlaps) and statistically. In the former instance, the number of new cases reported over time within a set of zip codes was overlaid with the measured wastewater data for that respective WRRF (Fig. 3 ). Overall, there was an insignificant improvement in correlations between the detected N1 gene SARS-CoV-2 numbers and clinical case data marked by the use of PMMoV normalization (Fig. 3) for WRRF 2-5. However, WRRF1 showed the greatest improvement by normalization, which may be due to a much smaller population size and geographical area of WRRF1 in comparison to the other plants, thus being prone, perhaps, to greater volatility. The normalization with PMMoV corrected unusually large peaks of SARS-CoV-2 presence during the monitoring period and provided trends that were not observed before normalization (for more detail see SI.)

Fig. 3.

Fig. 3

Figures showing correlations between wastewater values and zip code data for all WRRFs a

a) WRRF1; b) WRRF2; c) WRRF3; d) WRRF4; e) WRRF5. a both with and without normalization

Spearman's rank correlation analysis was used to evaluate the temporal relationship between the viral data in wastewater and the new clinical case numbers in the sewer sheds (all p < 0.05). To evaluate the temporal effect, the viral load was paired with the daily and the weekly averaged new cases, respectively, for the sewer sheds to calculate Spearman's rank correlation coefficients (Spearman's Rho). As data points from the wastewater were collected, on average once or twice per week, it was expected that there would be little correlation with these values and the clinical data, which was collected daily. However, it was uncertain, despite the expected poor correlation, if the use of PMMoV normalization would nonetheless have a significant impact on these results.

With the exception of WRRF1 (which had a slightly negative correlation) Spearman rank coefficients ranged from 0.137 to 0.177. This confirmed the presence of a poor correlation between wastewater and clinical data values. In agreement with other studies (Al-Faliti et al., 2022; Fitzgerald et al., 2021; Rusiñol et al., 2021), the large size WRRFs have a better correlation (Spearman's Rho = 0.64) between the viral loads and the daily clinical cases than the medium and small size WRRFs. The use of PMMoV normalization decreased Spearman coefficients for WRRFs 2, 3 and 4 but increases were observed for WRRF1 and WRRF5. WRRF1, as noted previously, had the greatest fluctuations in values of all WRRFs due to its small population size thus many values fell below the detection limit. WRRF5 had the lowest suspended solids content as well as the greatest flow and population size/area. For WRRF5, the Spearman rank coefficient improved from 0.158 to 0.220. Combined average values from all five WRRFs did not statistically change with the PMMoV normalization.

When the correlation was performed based on the total number of clinical cases reported in the week for which the sampling was done at the WRRFs was considered, the correlations improved for WRRFs 1-4. The Spearman rank coefficients ranged from 0.434 to 0.599 with WRRFs 2, 3 and 4 having the greatest similarity. WRRF5, possibly due to it having the greatest dilution, was the only WRRF positively impacted by the use of PMMoV normalization. WRRF3 and WRRF4 had no notable change, while WRRF1 and WRRF2 had negative impacts from the use of normalization. These findings demonstrate that wastewater can be used to monitor dynamic trends of COVID-19 infections in a community, regardless of the population size and magnitude of confirmed cases.

Many studies have claimed (Feng et al., 2021; McLerran, 2022; Stadler et al., 2020) that normalization based on the presence of PMMoV does not often significantly increase correlations significantly and can sometimes even make them worse. However, PMMoV and similar viral RNA are used to normalize wastewater data in an effort to validate the data obtained (Li et al., 2022a), and has an additional benefit, as it can also be used as an additional recovery tool (Feng et al., 2021). Therefore, use of PMMoV should be performed together with analysis of additional parameters such as rain fall data to assess the risk of infiltration and the presence of industrial wastewater contributions, where PMMoV is unlikely to be present.

3.3. The effects of flow rate, suspended solids, and dilution

To better understand the potential benefit of PMMoV, the effects of flow rate, suspended solids and dilution were evaluated further (Table 4 ). WRRF1 covered a smaller geographical area and also represented a comparatively smaller population thus it was more prone to fluctuation. At times, samples from this WRRF were collected on different dates than the other WRRFs due to the geographic location. Additionally, the flow rate for WRRF1 was approximately one order of magnitude lower than the other four WRRFs, but its population served was as much as fifty times less than the other WRRFs, thereby having the possibility of higher dilution. For WRRFs 1, 2 and 5, the reported flow also included recycling of the influent prior to the measurement. Average suspended solids values for each WRRF were also assessed and WRRF4 and WRRF5 had the lowest values. This also corresponded with the measured PMMoV values, as WRRF4 and WRRF5 showed the lowest PMMoV values (Table 4).

Table 4.

Flow rates, suspended solids, and PMMoV values for each WRRF, specifically during the period studied.

FLOW* (mgd) SS* (mg/L) PMMoV Values (gc/L)
WRRF1 1.0⁎⁎ 170.8* 4.68 × 109
WRRF2 17.6⁎⁎ 213.0 7.49 × 109
WRRF3 7.4 205.2 6.45 × 109
WRRF4 20.3 149.9 2.57 × 109
WRRF5 29.5⁎⁎ 140.7 1.46 × 109

Values reported are for Raw Influent (source for samples).

⁎⁎

These values reported are flow + recycle.

The use of the PMMoV and suspended solids data showed that WRRF5 samples were more diluted than the other large WRRFs and therefore it is likely that more values fell below the detection threshold. Although the solids content was similar for WRRF4 and WRRF5, the increased flow for WRRF5 also impacted the SARS-CoV-2 dilution. Another factor impacting dilutions, was a period in mid-February with prolonged snow accumulation followed by melting. This led to dilution, for both the N1 and N2 genes, where many values on Feb. 15th and 18th fell below or close to the threshold (Fig. 2). The usefulness of the PMMoV normalization can be seen in Fig. 2 for dates in early to mid-February, during which there was frequent snow and inclement weathers. The data illustrate how normalization can correct for these dilutions. The strong correlation between PMMoV values and suspended solids is well studied and although prone to variation and impact by non-fecal solids, there is often a strong relationship between the two (Kim et al., 2022). The PMMoV data obtained in this study was compared to the suspended solids for each WRRF of the studied time period (Figure 4 ).

Fig. 4.

Fig. 4

Relationship between the average concentration of Pepper Mild Mottle Virus (PMMoV) and Suspended Solids in the samples from the five WRRFs.

Although the relationship between PMMoV and the fecal solids or “fecal strength” is well documented (Graham et al., 2020; Kim et al., 2022; Wolfe et al., 2021), there are few papers specifically correlating the suspended solids of WRRFs to PMMoV levels, as is indicated in Fig. 4. This relationship, nevertheless, was not always a good tool for normalization as it only sometimes improved the Spearman Rank correlation (see above). This is concurrent with discrepancies in the literature. For example, Zhan et al. (2022) noted an increased correlation between wastewater and clinical cases through the use of PMMoV normalization (rs = 0.35 → rs = 0.73). They noted that this success occurred when clinical cases where low and the effects of normalization were more pronounced (Zhan et al., 2022). In contrast, Feng et al. (2021) found PMMoV normalization to either cause nominal improvement or decrease correlations. They posit this is due to the complex nature of wastewater and differences in how viruses interact in sewer environments. Most similar to this study, Duvallet et al. (2022) found that in some instances PMMoV increased correlation, while in others, it decreased correlations or had no effect. They attribute this to the variability of both the wastewater matrices and of the treatment plant design (Duvallet et al., 2022). Padilla-Reyes et al. (2022) noted that irrespective of normalization, weekly or biweekly correlations were stronger than daily correlation but that correlations also often had to be adjusted for time discrepancies (lags) between peaks in WW versus clinical detection. The data presented in this WRRF study did not have correlations that could be improved through lag time or other time-shift adjustments, but more frequent sampling could lead to that being observed.

4. Conclusions

Detection of SARS-CoV-2 using the genes N1 and N2 overall showed a good correlation between the results, but in some instances only one of the two genes was detected, which could be due to degradation of the target RNA. N1 values overall demonstrated a better fit and correlated better than N2 values with the clinical data based on zip code.

This analysis did not find a strong association between the viral loads in the wastewater and the daily clinical case numbers from the sewer sheds. However, a correlation was observed between wastewater data and weekly clinical cases for all the WRRFs, which is likely due to the delays in analyses and reporting of clinical data. This is in agreement with many studies, namely, that a weekly average or similar analysis provides a stronger correlation (Fahrenfeld et al., 2022; Halwatura et al., 2022; Li et al., 2022b; Shah et al., 2022). This study was also able to successfully use the PMMoV to normalize the data but did not lead to consistent increases in correlation between the wastewater data and the clinical data. The data that were normalized with PMMoV, however, did show a strong correlation with suspended solids levels for the wastewater influents thus supporting the accuracy of normalization to determine the proportion of fecal solids in a particular sample.

Variations in average numbers of SARS-CoV-2 were observed between WRRFs but these were not statistically significant. This may be due to the variability of wastewater and the overall large population sizes of the catchment areas. Improved understanding of these factors affecting the SARS-CoV-2 RNA concentration is needed to improve such prediction models. Overall, the findings of the analysis demonstrated that wastewater can be used to monitor the dynamic trend of COVID-19 infections in a community. Although correlations and predictions can strongly vary, WBE can be used as an early warning to signal, to determine rising cases in a given area, especially if these individuals are not clinically tested. This study, like others, (Ahmed et al., 2022; Karthikeyan et al., 2021a; Randazzo et al., 2020). finds that the use of wastewater analysis could be a cost-effective and sensitive strategy to successfully detect community transmission of the virus earlier than clinical reporting.

Supplementary data

Further data to support the results and conclusion driven in this paper is available in the Supplementary Information file.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

Acknowledgements

We would like to thank all WRRF associates and operators for organizing the sampling effort and collecting and providing wastewater samples. Funding for this study was provided by Dr. Schwartz, Chair of Civil and Environmental Engineering, University of Maryland during the time of the study as well as funding from Dr. Niemeier, Maryland Transportation Institute, and Dr. Kjellerup, Department of Civil and Environmental Engineering. A wonderful group of undergraduate students supported the sampling efforts: Naomi Lichtenstein, Victoria Miske and Michael McCreary. Advice and help from Laboratory Manager, Marya Anderson, made it possible to navigate laboratory activities during the time of research restrictions due to COVID-19 during spring and summer 2020.

Funding information

Funding for this study was provided by Dr. Schwartz, Chair of Civil and Environmental Engineering, University of Maryland during the time of the study as well as funding from Dr. Niemeier, Maryland Transportation Institute, and Dr. Kjellerup, Department of Civil and Environmental Engineering.

Footnotes

Relationship between SARS-CoV-2 in Wastewater and Clinical Data from Five Wastewater Sheds.

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.hazadv.2022.100159.

Appendix. Supplementary materials

mmc1.docx (9.1MB, docx)

References

  1. Ahmed W., Bivins A., Bertsch P.M., Bibby K., Gyawali P., Sherchan S.P., Simpson S.L., Thomas K.V., Verhagen R., Kitajima M. Intraday variability of indicator and pathogenic viruses in 1-h and 24-h composite wastewater samples: Implications for wastewater-based epidemiology. Environ. Res. 2021;193 doi: 10.1016/j.envres.2020.110531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ahmed W., Simpson S.L., Bertsch P.M., Bibby K., Bivins A., Blackall L.L., Bofill-Mas S., Bosch A., Brandão J., Choi P.M. Minimizing errors in RT-PCR detection and quantification of SARS-CoV-2 RNA for wastewater surveillance. Sci. Total Environ. 2022;805 doi: 10.1016/j.scitotenv.2021.149877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Al-Faliti M., Kotlarz N., McCall C., Harris A.R., Smith A.L., Stadler L.B., de los Reyes F.L., III, Delgado Vela J. Comparing Rates of Change in SARS-CoV-2 Wastewater Load and Clinical Cases in 19 Sewersheds Across Four Major Metropolitan Areas in the United States. ACS ES&T Water. 2022 [Google Scholar]
  4. Alygizakis N., Markou A.N., Rousis N.I., Galani A., Avgeris M., Adamopoulos P.G., Scorilas A., Lianidou E.S., Paraskevis D., Tsiodras S. Analytical methodologies for the detection of SARS-CoV-2 in wastewater: Protocols and future perspectives. TrAC Trends Anal. Chem. 2020 doi: 10.1016/j.trac.2020.116125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Asghar H., Diop O.M., Weldegebriel G., Malik F., Shetty S., El Bassioni L., Akande A.O., Al Maamoun E., Zaidi S., Adeniji A.J. Environmental surveillance for polioviruses in the Global Polio Eradication Initiative. J. Infect. Dis. 2014;210(1):S294–S303. doi: 10.1093/infdis/jiu384. suppl_. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bivins A., Lowry S., Wankhede S., Hajare R., Murphy H.M., Borchardt M., Labhasetwar P., Brown J. Microbial water quality improvement associated with transitioning from intermittent to continuous water supply in Nagpur, India. Water Res. 2021 doi: 10.1016/j.watres.2021.117301. [DOI] [PubMed] [Google Scholar]
  7. Bivins A., North D., Wu Z., Shaffer M., Ahmed W., Bibby K. Within-and between-Day Variability of SARS-CoV-2 RNA in Municipal Wastewater during Periods of Varying COVID-19 Prevalence and Positivity. ACS ES&T Water. 2021;1(9):2097–2108. [Google Scholar]
  8. Boxus M., Letellier C., Kerkhofs P. Real Time RT-PCR for the detection and quantitation of bovine respiratory syncytial virus. J. Virol. Methods. 2005;125(2):125–130. doi: 10.1016/j.jviromet.2005.01.008. [DOI] [PubMed] [Google Scholar]
  9. Centers for Disease Control and Prevention (CDC) 2022 Wastewater Surveillance Testing Methods.
  10. Chen M., Fan P., Liu Z., Pan R., Huang S., Li J., Zhao D. A SARS-CoV-2 familial cluster infection reveals asymptomatic transmission to children. J. Infect. Public Health. 2020;13(6):883–886. doi: 10.1016/j.jiph.2020.05.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Corman V.M., Landt O., Kaiser M., Molenkamp R., Meijer A., Chu D.K., Bleicker T., Brünink S., Schneider J., Schmidt M.L. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3) doi: 10.2807/1560-7917.ES.2020.25.3.2000045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. D'Aoust P.M., Mercier E., Montpetit D., Jia J.-J., Alexandrov I., Neault N., Baig A.T., Mayne J., Zhang X., Alain T. Quantitative analysis of SARS-CoV-2 RNA from wastewater solids in communities with low COVID-19 incidence and prevalence. Water Res. 2020;188 doi: 10.1016/j.watres.2020.116560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Duvallet, C., Wu, F., McElroy, K.A., Imakaev, M., Endo, N., Xiao, A., Zhang, J., Floyd-O'Sullivan, R., Powell, M.M. and Mendola, S. 2022. Nationwide Trends in COVID-19 Cases and SARS-CoV-2 RNA Wastewater Concentrations in the United States. ACS ES&T Water. [DOI] [PMC free article] [PubMed]
  14. Fahrenfeld N., Medina W.R.M., D'Elia S., Modica M., Ruiz A., McLane M. Comparison of residential dormitory COVID-19 monitoring via weekly saliva testing and sewage monitoring. Sci. Total Environ. 2022;814 doi: 10.1016/j.scitotenv.2021.151947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Feng, S., Roguet, A., McClary-Gutierrez, J.S., Newton, R.J., Kloczko, N., Meiman, J.G. and McLellan, S.L. 2021. Evaluation of sampling frequency and normalization of SARS-CoV-2 wastewater concentrations for capturing COVID-19 burdens in the community. medRxiv.
  16. Fitzgerald S.F., Rossi G., Low A.S., McAteer S.P., O'Keefe B., Findlay D., Cameron G.J., Pollard P., Singleton P.T., Ponton G. Site specific relationships between COVID-19 cases and SARS-CoV-2 viral load in wastewater treatment plant influent. Environ. Sci. Technol. 2021;55(22):15276–15286. doi: 10.1021/acs.est.1c05029. [DOI] [PubMed] [Google Scholar]
  17. Gandhi, M., Yokoe, D.S. and Havlir, D.V. 2020 Asymptomatic transmission, the Achilles’ heel of current strategies to control COVID-19, Mass Med. Soc. [DOI] [PMC free article] [PubMed]
  18. Graham K.E., Loeb S.K., Wolfe M.K., Catoe D., Sinnott-Armstrong N., Kim S., Yamahara K.M., Sassoubre L.M., Mendoza Grijalva L.M., Roldan-Hernandez L. SARS-CoV-2 RNA in wastewater settled solids is associated with COVID-19 cases in a large urban sewershed. Environ. Sci. Technol. 2020;55(1):488–498. doi: 10.1021/acs.est.0c06191. [DOI] [PubMed] [Google Scholar]
  19. Halwatura, L.M., Mclerran, I.S., Weglarski, D.L., Ahmed, Z.U., Ye, Y., Bradley, I.M. and Aga, D.S. 2022. Complementing RNA Detection with Pharmaceutical Monitoring for Early Warning of Viral Outbreaks through Wastewater-Based Epidemiology. Environ. Sci. Technol. Lett..
  20. Hsu, S.-Y., Bayati, M.B., Li, C., Hsieh, H.-Y., Belenchia, A., Johnson, H., Klutts, J., Reynolds, M., Semkiw, E. and Wenzel, J. 2022. Biomarkers Selection for Population Normalization in SARS-CoV-2 Wastewater-based Epidemiology. medRxiv. [DOI] [PMC free article] [PubMed]
  21. Jafferali, M.H., Khatami, K., Atasoy, M., Birgersson, M., Williams, C. and Cetecioglu, Z. 2020. Benchmarking virus concentration methods for quantification of SARS-CoV-2 in raw wastewater. Sci. Total Environ., 142939. [DOI] [PMC free article] [PubMed]
  22. Karthikeyan S., Nguyen A., McDonald D., Zong Y., Ronquillo N., Ren J., Zou J., Farmer S., Humphrey G., Henderson D. Rapid, large-scale wastewater surveillance and automated reporting system enable early detection of nearly 85% of COVID-19 cases on a university campus. mSystems. 2021;6(4):e00793. doi: 10.1128/mSystems.00793-21. -00721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Karthikeyan S., Ronquillo N., Belda-Ferre P., Alvarado D., Javidi T., Longhurst C.A., Knight R. High-throughput wastewater SARS-CoV-2 detection enables forecasting of community infection dynamics in San Diego County. mSystems. 2021;6(2):e00045. doi: 10.1128/mSystems.00045-21. -00021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kaya D., Niemeier D., Ahmed W., Kjellerup B.V. Evaluation of multiple analytical methods for SARS-CoV-2 surveillance in wastewater samples. Sci. Total Environ. 2022;808 doi: 10.1016/j.scitotenv.2021.152033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kim S., Kennedy L.C., Wolfe M.K., Criddle C.S., Duong D.H., Topol A., White B.J., Kantor R.S., Nelson K.L., Steele J.A. SARS-CoV-2 RNA is enriched by orders of magnitude in primary settled solids relative to liquid wastewater at publicly owned treatment works. Water Res. 2022;8(4):757–770. doi: 10.1039/d1ew00826a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kitajima M., Sassi H.P., Torrey J.R. Pepper mild mottle virus as a water quality indicator. npj Clean Water. 2018;1(1):1–9. [Google Scholar]
  27. Larsen D.A., Wigginton K.R. Tracking COVID-19 with wastewater. Nat. Biotechnol. 2020;38(10):1151–1153. doi: 10.1038/s41587-020-0690-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lee H.-W., Lee H.-M., Yoon S.-R., Kim S.H., Ha J.-H. Pretreatment with propidium monoazide/sodium lauroyl sarcosinate improves discrimination of infectious waterborne virus by RT-qPCR combined with magnetic separation. Environ. Pollut. 2018;233:306–314. doi: 10.1016/j.envpol.2017.10.081. [DOI] [PubMed] [Google Scholar]
  29. Li, L., Mazurowski, L., Dewan, A., Carine, M., Haak, L., Guarin, T.C., Dastjerdi, N.G., Gerrity, D., Mentzer, C. and Pagilla, K.R. 2022a. Longitudinal monitoring of SARS-CoV-2 in wastewater using viral genetic markers and the estimation of unconfirmed COVID-19 cases. Sci. Total Environ., 152958. [DOI] [PMC free article] [PubMed]
  30. Li L., Mazurowski L., Dewan A., Carine M., Haak L., Guarin T.C., Dastjerdi N.G., Gerrity D., Mentzer C., Pagilla K.R. Longitudinal monitoring of SARS-CoV-2 in wastewater using viral genetic markers and the estimation of unconfirmed COVID-19 cases. Sci. Total Environ. 2022;817 doi: 10.1016/j.scitotenv.2022.152958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Li, X., Zhang, S., Shi, J., Luby, S.P. and Jiang, G. 2021. Uncertainties in estimating SARS-CoV-2 prevalence by wastewater-based epidemiology. Chem. Eng. J., 129039. [DOI] [PMC free article] [PubMed]
  32. Lu D., Huang Z., Luo J., Zhang X., Sha S. Primary concentration–The critical step in implementing the wastewater based epidemiology for the COVID-19 pandemic: A mini-review. Sci. Total Environ. 2020;747 doi: 10.1016/j.scitotenv.2020.141245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lu, F.S., Nguyen, A., Link, N. and Santillana, M. 2020b. Estimating the prevalence of COVID-19 in the United States: three complementary approaches.
  34. Lu X., Wang L., Sakthivel S.K., Whitaker B., Murray J., Kamili S., Lynch B., Malapati L., Burke S.A., Harcourt J. US CDC real-time reverse transcription PCR panel for detection of severe acute respiratory syndrome coronavirus 2. Emerg. Infect. Dis. 2020;26(8):1654. doi: 10.3201/eid2608.201246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Maestre J.P., Jarma D., Jia-Rong F.Y., Siegel J.A., Horner S.D., Kinney K.A. Distribution of SARS-CoV-2 RNA signal in a home with COVID-19 positive occupants. Sci. Total Environ. 2021;778 doi: 10.1016/j.scitotenv.2021.146201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. McLerran, I. (2022) Long-Term Surveillance Testing of SARS-CoV-2: Implementation and Normalization of Methods for a Community Dashboard, State University of New York at Buffalo.
  37. Medema, G., Been, F., Heijnen, L. and Petterson, S. 2020. Implementation of environmental surveillance for SARS-CoV-2 virus to support public health decisions: Opportunities and challenges. Curr. Opin. Environ. Sci. Health. [DOI] [PMC free article] [PubMed]
  38. Michael-Kordatou I., Karaolia P., Fatta-Kassinos D. Sewage analysis as a tool for the COVID-19 pandemic response and management: the urgent need for optimised protocols for SARS-CoV-2 detection and quantification. J. Environ. Chem. Eng. 2020;8(5) doi: 10.1016/j.jece.2020.104306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Padilla-Reyes D.A., Álvarez M.M., Mora A., Cervantes-Avilés P.A., Kumar M., Loge F.J., Mahlknecht J. Acquired insights from the long-term surveillance of SARS-CoV-2 RNA for COVID-19 monitoring: The case of Monterrey Metropolitan Area (Mexico) Environ. Res. 2022;210 doi: 10.1016/j.envres.2022.112967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Peccia J., Zulli A., Brackney D.E., Grubaugh N.D., Kaplan E.H., Casanovas-Massana A., Ko A.I., Malik A.A., Wang D., Wang M. Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics. Nat. Biotechnol. 2020;38(10):1164–1167. doi: 10.1038/s41587-020-0684-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Pérez-Cataluña A., Cuevas-Ferrando E., Randazzo W., Falcó I., Allende A., Sánchez G. Comparing analytical methods to detect SARS-CoV-2 in wastewater. Sci. Total Environ. 2021;758 doi: 10.1016/j.scitotenv.2020.143870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Prado T., Fumian T.M., Mannarino C.F., Resende P.C., Motta F.C., Eppinghaus A.L.F., do Vale V.H.C., Braz R.M.S., de Andrade J.d.S.R., Maranhão A.G. Wastewater-based epidemiology as a useful tool to track SARS-CoV-2 and support public health policies at municipal level in Brazil. Water Res. 2021;191 doi: 10.1016/j.watres.2021.116810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Randazzo W., Cuevas-Ferrando E., Sanjuán R., Domingo-Calap P., Sánchez G. Metropolitan wastewater analysis for COVID-19 epidemiological surveillance. Int. J. Hyg. Environ. Health. 2020;230 doi: 10.1016/j.ijheh.2020.113621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Rosario K., Symonds E.M., Sinigalliano C., Stewart J., Breitbart M. Pepper mild mottle virus as an indicator of fecal pollution. Appl. Environ. Microbiol. 2009;75(22):7261–7267. doi: 10.1128/AEM.00410-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Rusiñol M., Zammit I., Itarte M., Forés E., Martínez-Puchol S., Girones R., Borrego C., Corominas L., Bofill-Mas S. Monitoring waves of the COVID-19 pandemic: Inferences from WWTPs of different sizes. Sci. Total Environ. 2021;787 doi: 10.1016/j.scitotenv.2021.147463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Saththasivam J., El-Malah S.S., Gomez T.A., Jabbar K.A., Remanan R., Krishnankutty A.K., Ogunbiyi O., Rasool K., Ashhab S., Rashkeev S. COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar. Sci. Total Environ. 2021;774 doi: 10.1016/j.scitotenv.2021.145608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Shah S., Gwee S.X.W., Ng J.Q.X., Lau N., Koh J., Pang J. Wastewater surveillance to infer COVID-19 transmission: A systematic review. Sci. Total Environ. 2022;804 doi: 10.1016/j.scitotenv.2021.150060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sherchan S.P., Shahin S., Ward L.M., Tandukar S., Aw T.G., Schmitz B., Ahmed W., Kitajima M. First detection of SARS-CoV-2 RNA in wastewater in North America: a study in Louisiana, USA. Sci. Total Environ. 2020;743 doi: 10.1016/j.scitotenv.2020.140621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Stadler, L., Ensor, K., Clark, J., Kalvapalle, P., LaTurner, Z.W., Mojica, L., Terwilliger, A., Zhuo, Y., Ali, P. and Avadhanula, V. 2020. Wastewater analysis of SARS-CoV-2 as a predictive metric of positivity rate for a major metropolis.
  50. Valarcher J.-F., Taylor G. Bovine respiratory syncytial virus infection. Vet. Res. 2007;38(2):153–180. doi: 10.1051/vetres:2006053. [DOI] [PubMed] [Google Scholar]
  51. Weidhaas J., Aanderud Z.T., Roper D.K., VanDerslice J., Gaddis E.B., Ostermiller J., Hoffman K., Jamal R., Heck P., Zhang Y. Correlation of SARS-CoV-2 RNA in wastewater with COVID-19 disease burden in sewersheds. Sci. Total Environ. 2021;775 doi: 10.1016/j.scitotenv.2021.145790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Wolfe M.K., Archana A., Catoe D., Coffman M.M., Dorevich S., Graham K.E., Kim S., Grijalva L.M., Roldan-Hernandez L., Silverman A.I. Scaling of SARS-CoV-2 RNA in settled solids from multiple wastewater treatment plants to compare incidence rates of laboratory-confirmed COVID-19 in their sewersheds. Environ. Sci. Technol. Lett. 2021;8(5):398–404. doi: 10.1021/acs.estlett.1c00184. [DOI] [PubMed] [Google Scholar]
  53. World Health Organization 2022 WHO Coronavirus (COVID-19) Dashboard.
  54. Wu, F., Xiao, A., Zhang, J., Gu, X., Lee, W.L., Kauffman, K., Hanage, W., Matus, M., Ghaeli, N. and Endo, N. 2020a. SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases. medRxiv. [DOI] [PMC free article] [PubMed]
  55. Wu, F., Xiao, A., Zhang, J., Moniz, K., Endo, N., Armas, F., Bonneau, R., Brown, M.A., Bushman, M. and Chai, P.R. 2020b. SARS-CoV-2 titers in wastewater foreshadow dynamics and clinical presentation of new COVID-19 cases. Medrxiv. [DOI] [PMC free article] [PubMed]
  56. Xagoraraki, I. and O'Brien, E. (2020) Women in water quality, pp. 75-97, Springer.
  57. Xu T., Huang R., Zhu L., Wang J., Cheng J., Zhang B., Zhao H., Chen K., Shao H., Zhu C. Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection. J. Med. Virol. 2020;92(10):1884–1889. doi: 10.1002/jmv.25944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Zhan, Q., Babler, K.M., Sharkey, M.E., Amirali, A., Beaver, C.C., Boone, M.M., Comerford, S., Cooper, D., Cortizas, E.M. and Currall, B.B. 2022. Relationships between SARS-CoV-2 in wastewater and COVID-19 clinical cases and hospitalizations, with and without normalization against indicators of human waste. ACS ES&T Water. [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

mmc1.docx (9.1MB, docx)

Articles from Journal of Hazardous Materials Advances are provided here courtesy of Elsevier

RESOURCES